Addiction

Truth Initiative’s EX Program Launches First Campaign to Include Nicotine Pouches as Gen Z Faces Troubling Rise in Use of Multiple Products

New Outsmart Nicotine ads, which also include cigarettes and e-cigarettes, highlight the cycle of stress, cravings and nicotine addiction, and...

Red Light Holland Reports Continued Expansion of Filament Health’s PEX010 Clinical Network with New License Agreements and Research Shipments

Three new license agreements signed and two research shipments completed in March 2026, spanning institutions in Australia, the United Kingdom,...

Neurolief Secures Additional $6 Million Investment Following FDA Approval of Proliv™Rx, Expanding Access to Brain Neuromodulation Therapy for Patients with Inadequate Response to Antidepressants

Investment accelerates U.S. rollout of a scalable, at-home brain neuromodulation therapy for patients with depression and inadequate response to at least...

Pacira BioSciences to Present Real-World Data on EXPAREL® Showing Reduced Cost of Care at Orthopaedic Research Society 2026 Annual Meeting

-- Studies highlight reduced total cost of care and select healthcare resource utilization outcomes in total knee arthroplasty (TKA) and...

Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline’s Receptor Selectivity to Low Nausea Rates and Favorable Tolerability

Preclinical findings show cytisinicline's minimal 5-HT3 serotonin receptor binding offers insight into observed low nausea rates in smoking and vaping...

Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline’s Receptor Selectivity to Low Nausea Rates and Favorable Tolerability

Preclinical findings show cytisinicline's minimal 5-HT3 serotonin receptor binding offers insight into observed low nausea rates in smoking and vaping...

BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD

BURLINGTON, Mass. and JERUSALEM, March 26, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...

BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD

BURLINGTON, Mass. and JERUSALEM, March 26, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...

Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain

Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026

SEATTLE and VANCOUVER, British Columbia, March 17, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty...

AgelessRx 2026: Longevity Telehealth Platform Overview — Treatments, Pricing, Compounded Medications, and What Prospective Patients Should Know

An Informational Consumer Analysis of AgelessRx's Prescription Process, NAD+ Therapies, GLP-1 and Compounded Semaglutide Options, Off-Label Longevity Medications, and Cash-Pay...

error: Content is protected !!